Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention

Condition:   Sars-CoV2 Interventions:   Drug: Lovenox 40 MG in 0.4 mL Prefilled Syringe;   Device: Ultrasound of the lower limbs Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang Withdrawn
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials